About Us

The National Research Center for Women & Families promotes the health and safety of women, children, and families, by using objective, research-based information to encourage new, more effective programs and policies. The Center achieves its mission by gathering and analyzing information and translating that information into clearly presented facts and policy implications that are made widely available to the public, the media, and policy makers.

Read more about the mission of the National Research Center for Women & Families. Read More >>

In The News

Senate panel approves tighter oversight of compounding pharmacies, but bill is under fire

Washington Post. May 23, 2013. Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks. Read More >


Angelina Jolie’s Decision

Huffington Post. 16 May 2013. Dr. Diana Zuckerman writes, “Let’s use Angelina Jolie’s announcement to have a frank discussion of the treatment choices for breast cancer and to encourage women to make decisions based on their own situations not on the choice of a celebrity, however admirable she is.” Read More >


What You Need To Know

2013 Foremother Awards and Health Policy Heroes

It was fun and inspiriting at our 2013 Foremothers and Health Policy Heroes Awards luncheon at the elegant Cosmos Clubs.  Find more here.

Is that Screening Necessary? Physician Experts Say Maybe Not

Twenty-five major medical groups made recommendations about the kinds of screening and tests you DON’T need.  Why pay for tests that won’t help and might even hurt? To learn what they say about certain popular tests, check out this article.

FDA asks if an antidepressant and and an epilsepsy drug reduce hot flashes?  We say no.

Read our testimony to the FDA about an antidepressant and an epilepsy drug for the treatment of hot flashes.

What You Need to Know About YAZ Birth Control

YAZ, Yasmin, Beyaz, and other drospirenone hormonal birth control pills have been found to have an increased risk of serious blood clots. However, the FDA has not taken the pills off the market or demanded a black box warning. To learn the full story, read our article. For more information about all birth control methods, check out this overview.